摘要
本文以气血学说为理论基础,以临床表现及微循环、血液流变性研究结果为论据,提出人体衰老的主要机制在于气血失调、气虚血瘀的观点。同时,应用具有益气化瘀作用的方药“衡法Ⅱ号”进行抗衰老临床与实验研究,取得肯定效果,证实益气化瘀药物可逆转气血失衡,使气血重新趋于平衡而达到延年益寿的目的。
On the basis of the theory of Qi and blood, the clinical manifestations and the results of research on microcirculation and blood rheology, the writer puts forward the idea that the main mechanism of physical senility is deficiency of Qi and stagnancy of blood. Clinical and experimental studies using Hengfa Ⅱ, which has the function of supplementing Qi and removing blood stasis, for senility have yielded definite results which prove the drug can adjust the balance of Qi and blood for the purpose of achieving longevity.
出处
《中国医药学报》
CSCD
北大核心
1989年第2期10-12,共3页
China Journal of Traditional Chinese Medicine and Pharmacy
